Rawan Omar

Rawan Omar

Auto-generated profile, based on publicly available information

Rawan Omar

Department of Chemical Engineering and Russell Berrie Nanotechnology Institute Technion‐Israel Institute of Technology Haifa Israel

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2024 in ACS Sensors
Verified
Journal Article
Open access
RORawan Omar
Rawan Omar
WSWalaa Saliba
Walaa Saliba
MKMuhammad Khatib
Muhammad Khatib
YZYoubin Zheng
Youbin Zheng
CPCalvin Pieters
Calvin Pieters
HHHossam Haick
Hossam Haick
Cardiac monitoring after heart surgeries is crucial for health maintenance and detecting postoperative complications early. However, current methods like rigid implants have limitations, as they require performing second complex surgeries for removal, increasing infection and inflammation risks, thus prompting research for improved sensing monitoring technologies. Herein, we introduce a nanosensor platform that is biodegradable, biocompatible, and integrated with multifunctions, suitable for use as implants for cardiac monitoring. The device has two electrochemical biosensors for sensing lactic acid and pH as well as a pressure sensor and a chemiresistor array for detecting volatile organic compounds. Its biocompatibility with myocytes has been tested in vitro, and its biodegradability and sensing function have been proven with ex vivo experiments using a three-dimensional (3D)-printed heart model and 3D-printed cardiac tissue patches. Moreover, an artificial intelligence-based predictive model was designed to fuse sensor data for more precise health assessment, making it a suitable candidate for clinical use. This sensing platform promises impactful applications in the realm of cardiac patient care, laying the foundation for advanced life-saving developments.

13 October 2025 in Progress in Materials Science
Verified
Journal Article
Open access
YLYi Liu
Yi Liu
RORawan Omar
Rawan Omar
GLGang Li
Gang Li
PZPengcheng Zhou
Pengcheng Zhou
YZYujie Zhang
Yujie Zhang
Yan WangYan Wang
Yan Wang

17 August 2025 in Advanced Materials Technologies
Verified
Journal Article
Open access
RORawan Omar
Rawan Omar
JYJiawei Yang
Jiawei Yang
THTan‐Phat Huynh
Tan‐Phat Huynh
KGKiran Gulia
Kiran Gulia
STSooyun Caroline Tavolacci
Sooyun Caroline Tavolacci
HHHossam Haick
Hossam Haick
Contemporary electronic devices generate substantial quantities of electronic waste (e‐waste), presenting a significant environmental challenge and exerting considerable pressure on the health of the Earth's ecosystems. Owing to the industry's heavy reliance on limited resources and the use of nondegradable components, innovation is necessary in device design, use, and end‐of‐life management. This review delves into the growing field of advanced materials for sustainable electronics, emphasizing their critical role in transforming the industry toward sustainability. The use of advanced materials in a sustainable way offers promising opportunities for reducing environmental harm and health risks while enhancing device performance and longevity. This interdisciplinary review explores themes such as energy efficiency, sustainable materials, recycling potential, resource consumption reduction, and environmental and health monitoring. It aims to illuminate recent progress, highlight ongoing challenges, and examine future prospects and applications for advanced materials in the pursuit of responsible electronics.


6 March 2024 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
RORawan Omar
Rawan Omar
STSooyun Caroline Tavolacci
Sooyun Caroline Tavolacci
LLLathan Liou
Lathan Liou
DVDillan F. Villavisanis
Dillan F. Villavisanis
YBYoav Y. Broza
Yoav Y. Broza
HHHossam Haick
Hossam Haick
Hospitalized patients with Coronavirus disease 2019 (COVID-19) are highly susceptible to in-hospital mortality and cardiac complications such as atrial arrhythmias (AA). However, the utilization of biomarkers such as potassium, B-type natriuretic peptide, albumin, and others for diagnosis or the prediction of in-hospital mortality and cardiac complications has not been well established. The study aims to investigate whether biomarkers can be utilized to predict mortality and cardiac complications among hospitalized COVID-19 patients. Data were collected from 6,927 hospitalized COVID-19 patients from March 1, 2020, to March 31, 2021 at one quaternary (Henry Ford Health) and five community hospital registries (Trinity Health Systems). A multivariable logistic regression prediction model was derived using a random sample of 70% for derivation and 30% for validation. Serum values, demographic variables, and comorbidities were used as input predictors. The primary outcome was in-hospital mortality, and the secondary outcome was onset of AA. The associations between predictor variables and outcomes are presented as odds ratio (OR) with 95% confidence intervals (CIs). Discrimination was assessed using area under ROC curve (AUC). Calibration was assessed using Brier score. The model predicted in-hospital mortality with an AUC of 90% [95% CI: 88%, 92%]. In addition, potassium showed promise as an independent prognostic biomarker that predicted both in-hospital mortality, with an AUC of 71.51% [95% Cl: 69.51%, 73.50%], and AA with AUC of 63.6% [95% Cl: 58.86%, 68.34%]. Within the test cohort, an increase of 1 mEq/L potassium was associated with an in-hospital mortality risk of 1.40 [95% CI: 1.14, 1.73] and a risk of new onset of AA of 1.55 [95% CI: 1.25, 1.93]. This cross-sectional study suggests that biomarkers can be used as prognostic variables for in-hospital mortality and onset of AA among hospitalized COVID-19 patients.